NASDAQ:SNMX - Senomyx Stock Price, Price Target & More

Get Started

$1.39 +0.01 (+0.72 %)

(As of 05/27/2018 03:57 AM ET)

Previous Close$1.39

Today's Range$1.3340 - $1.40

52-Week Range$0.56 - $1.71

Volume36,628 shs

Average Volume115,302 shs

Market Capitalization$66.66 million

P/E Ratio-46.33

Dividend YieldN/A

Beta1.42

About Senomyx (NASDAQ:SNMX)

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive SNMX News and Ratings via Email

Sign-up to receive the latest news and ratings for SNMX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commercial physical research

Sub-IndustryN/A

SectorConsumer Staples

SymbolNASDAQ:SNMX

CUSIPN/A

Webwww.senomyx.com

Phone858-646-8300

Debt

Debt-to-Equity RatioN/A

Current Ratio5.43

Quick Ratio5.02

Price-To-Earnings

Trailing P/E Ratio-46.33

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$29.32 million

Price / Sales2.29

Cash FlowN/A

Price / CashN/A

Book Value$0.36 per share

Price / Book3.86

Profitability

EPS (Most Recent Fiscal Year)($0.03)

Net Income$-1,260,000.00

Net Margins-5.66%

Return on Equity-10.75%

Return on Assets-7.06%

Miscellaneous

Employees56

Outstanding Shares48,300,000

Senomyx (NASDAQ:SNMX) Frequently Asked Questions

What is Senomyx's stock symbol?

Senomyx trades on the NASDAQ under the ticker symbol "SNMX."

How were Senomyx's earnings last quarter?

Senomyx (NASDAQ:SNMX) released its quarterly earnings data on Thursday, April, 26th. The specialty chemicals company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.01. The specialty chemicals company had revenue of $3.11 million for the quarter. Senomyx had a negative return on equity of 10.75% and a negative net margin of 5.66%. View Senomyx's Earnings History.

Who are some of Senomyx's key competitors?

Some companies that are related to Senomyx include Anavex Life Sciences (AVXL), HedgePath Pharmaceuticals (HPPI), Luna Innovations (LUNA), Dyadic International, Inc common stock (DYAI), Cleveland BioLabs (CBLI), BIOQUAL (BIOQ), Vitality Biopharma (VBIO), Protalex (PRTX), Bioanalytical Systems (BASI), US Stem Cell (USRM), Oxygen Biotherapeutics (TENX), ALGAE TEC Ltd/S (ALGXY), Geovax Labs (GOVX) and Redpoint Bio (RPBC).

Who are Senomyx's key executives?

Senomyx's management team includes the folowing people:

Mr. Kent Snyder, Exec. Chairman (Age 64)
Mr. John W. Poyhonen MBA, Chief Exec. Officer, Pres and Director (Age 58)
Ms. Catherine C. Lee, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)
Ms. Sharon Wicker, Sr. VP & Chief Commercial Devel. Officer (Age 62)
Mr. David C. Humphrey, VP of Fin.

Has Senomyx been receiving favorable news coverage?

Headlines about SNMX stock have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Senomyx earned a media sentiment score of 0.13 on Accern's scale. They also gave news stories about the specialty chemicals company an impact score of 46.77 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Senomyx's major shareholders?

Senomyx's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Cowen Prime Services LLC (1.37%) and Quantum Capital Management (0.58%). Company insiders that own Senomyx stock include John Poyhonen and Mary Ann Gray. View Institutional Ownership Trends for Senomyx.

Which major investors are selling Senomyx stock?

SNMX stock was sold by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC. View Insider Buying and Selling for Senomyx.

Which major investors are buying Senomyx stock?

SNMX stock was purchased by a variety of institutional investors in the last quarter, including Quantum Capital Management. Company insiders that have bought Senomyx stock in the last two years include John Poyhonen and Mary Ann Gray. View Insider Buying and Selling for Senomyx.

How do I buy shares of Senomyx?

Shares of SNMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Senomyx's stock price today?

One share of SNMX stock can currently be purchased for approximately $1.39.

How big of a company is Senomyx?

Senomyx has a market capitalization of $66.66 million and generates $29.32 million in revenue each year. The specialty chemicals company earns $-1,260,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Senomyx employs 56 workers across the globe.

How can I contact Senomyx?

Senomyx's mailing address is 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA, 92121. The specialty chemicals company can be reached via phone at 858-646-8300 or via email at [email protected]

MarketBeat Community Rating for Senomyx (SNMX)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		133 (Vote Outperform)
Underperform Votes:		143 (Vote Underperform)
Total Votes:		276

MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe SNMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNMX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Senomyx (NASDAQ:SNMX) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	Hold	Hold	Hold
Consensus Rating Score:	N/A	2.00	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	$2.00	$2.00	$2.00
Price Target Upside:	N/A	128.62% upside	128.62% upside	128.62% upside

Senomyx (NASDAQ:SNMX) Consensus Price Target History

Price Target History for Senomyx (NASDAQ:SNMX)

Senomyx (NASDAQ:SNMX) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/2/2017	Roth Capital	Set Price Target	Hold	$2.00	Low
10/28/2016	Needham & Company LLC	Downgrade	Buy ➝ Hold		N/A
10/28/2016	Craig Hallum	Downgrade	Buy ➝ Hold	$2.00	N/A

(Data available from 5/27/2016 forward)

Senomyx (NASDAQ:SNMX) Earnings History and Estimates Chart

Earnings by Quarter for Senomyx (NASDAQ:SNMX)

Senomyx (NASDAQ SNMX) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/26/2018	Q1 2018	($0.07)	($0.08)		$3.11 million	View	N/A
3/8/2018	Q4 2017	($0.06)	$0.15	$4.83 million	$14.93 million	View	Listen
11/2/2017	Q3 2017	($0.07)	($0.05)		$5.06 million	View	N/A
7/27/2017	Q2 2017	($0.07)	($0.06)	$4.60 million	$4.87 million	View	N/A
4/28/2017	Q1 2017	($0.08)	($0.07)	$4.22 million	$4.47 million	View	N/A
3/2/2017	Q4 2016	($0.09)	($0.08)	$4.30 million	$4.20 million	View	Listen
10/27/2016	Q316	($0.07)	($0.05)	$5.36 million	$6.00 million	View	Listen
7/28/2016	Q2	($0.06)	($0.05)	$6.20 million	$6.60 million	View	Listen
4/28/2016	Q1	($0.0770)	($0.05)	$5.78 million	$6.30 million	View	Listen
3/3/2016	Q4	($0.07)	($0.07)	$6.97 million	$6.27 million	View	Listen
10/29/2015	Q315	($0.06)	($0.05)	$7.62 million	$7.40 million	View	Listen
7/30/2015	Q215	($0.10)	($0.06)	$6.13 million	$6.20 million	View	Listen
4/30/2015	Q115	($0.10)	($0.11)	$5.86 million	$5.00 million	View	Listen
2/26/2015	Q414	($0.11)	($0.07)	$6.60 million	$6.30 million	View	Listen
11/6/2014	Q314	($0.08)	($0.10)	$7.90 million	$5.90 million	View	Listen
7/31/2014	Q214	($0.08)	($0.06)	$7.46 million	$7.34 million	View	Listen
5/1/2014	Q114	($0.07)	($0.05)	$7.60 million	$8.20 million	View	Listen
3/13/2014	Q413	($0.06)	($0.08)	$7.82 million	$7.41 million	View	Listen
11/12/2013	Q313	($0.05)	($0.09)	$8.19 million	$6.70 million	View	Listen
8/1/2013	Q2 2013	($0.06)	($0.06)	$7.64 million	$7.70 million	View	Listen
4/25/2013	Q1 2013	($0.04)	($0.07)	$8.45 million	$7.48 million	View	Listen
3/15/2013	Q4 2012	($0.04)	($0.06)	$8.39 million	$6.73 million	View	Listen
11/8/2012	Q312	($0.07)	($0.05)	$7.66 million	$7.90 million	View	N/A
8/7/2012		($0.08)	($0.08)			View	N/A
5/3/2012		($0.05)	($0.05)			View	N/A
3/1/2012		($0.05)	($0.04)			View	N/A
10/27/2011		($0.08)	($0.07)			View	N/A
8/5/2011		($0.09)	($0.08)			View	N/A
4/29/2011	Q1 2011	($0.06)	($0.03)			View	N/A
3/3/2011	Q4 2010	($0.11)	($0.01)			View	N/A
11/4/2010	Q3 2010	($0.12)	($0.10)			View	N/A
8/5/2010	Q2 2010	($0.14)	($0.12)			View	N/A
4/29/2010	Q1 2010	($0.16)	($0.05)			View	N/A
2/4/2010	Q4 2009	($0.16)	($0.15)			View	N/A
11/5/2009	Q3 2009	($0.21)	($0.20)			View	N/A
8/4/2009	Q2 2009	($0.21)	($0.26)			View	N/A
5/7/2009	Q1 2009	($0.21)	($0.24)			View	N/A
2/12/2009	Q4 2008	($0.20)	($0.26)			View	N/A
11/6/2008	Q3 2008	($0.21)	($0.21)			View	N/A
8/7/2008	Q2 2008	($0.20)	($0.25)			View	N/A
4/24/2008	Q1 2008	($0.20)	($0.16)			View	N/A
2/7/2008	Q4 2007	($0.21)	($0.15)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Senomyx (NASDAQ:SNMX) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Senomyx (NASDAQ SNMX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 13.00%
Institutional Ownership Percentage: 30.19%

Insider Trading History for Senomyx (NASDAQ:SNMX)

Institutional Ownership by Quarter for Senomyx (NASDAQ:SNMX)

Senomyx (NASDAQ SNMX) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2017	Mary Ann Gray	Director	Buy	10,000	$1.00	$10,000.00	10,000
3/23/2017	John Poyhonen	CEO	Buy	50,000	$0.98	$49,000.00
3/11/2015	Sharon Wicker	SVP	Buy	20,000	$4.33	$86,600.00
10/1/2014	Jay M Phd Short	Director	Sell	7,500	$8.16	$61,200.00
9/17/2014	Donald Karanewsky	VP	Sell	20,000	$8.61	$172,200.00
9/11/2014	Sharon Wicker	SVP	Sell	40,525	$9.12	$369,588.00
9/10/2014	Antony E Rogers	CFO	Sell	14,800	$9.00	$133,200.00
9/10/2014	Donald Karanewsky	VP	Sell	20,000	$8.50	$170,000.00
9/10/2014	Sharon Wicker	SVP	Sell	21,988	$9.00	$197,892.00
6/19/2014	Donald Karanewsky	VP	Sell	20,000	$8.86	$177,200.00
6/19/2014	Sharon Wicker	SVP	Sell	50,100	$9.12	$456,912.00
6/13/2014	Antony E Rogers	CFO	Sell	2,997	$8.41	$25,204.77
6/12/2014	Donald Karanewsky	VP	Sell	20,000	$8.50	$170,000.00
6/10/2014	Stephen A Block	Director	Sell	28,750	$8.21	$236,037.50
6/5/2014	John Poyhonen	CEO	Sell	37,600	$8.00	$300,800.00
5/9/2014	Michael E Herman	Director	Buy	14,000	$6.47	$90,580.00
4/17/2014	Donald Karanewsky	VP	Sell	20,000	$8.72	$174,400.00
4/11/2014	Kent Snyder	Director	Sell	45,688	$9.88	$451,397.44
4/9/2014	Kent Snyder	Director	Sell	45,688	$10.60	$484,292.80
4/7/2014	Kent Snyder	Director	Sell	68,532	$11.13	$762,761.16
4/7/2014	Sharon Wicker	SVP	Sell	31,154	$10.61	$330,543.94
4/2/2014	Kent Snyder	Director	Sell	68,532	$11.06	$757,963.92
4/1/2014	Jay M Phd Short	Director	Sell	11,590	$10.66	$123,549.40
3/17/2014	Michael E Herman	Director	Buy	33,000	$10.09	$332,970.00
1/14/2014	Jay M Phd Short	Director	Sell	4,090	$6.50	$26,585.00
12/23/2013	Sharon Wicker	SVP	Sell	13,749	$4.80	$65,995.20
12/20/2013	Sharon Wicker	SVP	Sell	38,565	$4.71	$181,641.15
12/3/2013	Sharon Wicker	SVP	Sell	91,196	$4.24	$386,671.04
11/25/2013	Sharon Wicker	SVP	Sell	12,269	$4.21	$51,652.49

(Data available from 1/1/2013 forward)

Senomyx (NASDAQ SNMX) News Headlines

Source:

Date	Headline
	Head to Head Comparison: Senomyx (SNMX) versus Anavex Life Sciences (AVXL) www.americanbankingnews.com - May 26 at 10:40 AM
	Senomyx (SNMX) and Pieris Pharmaceuticals (PIRS) Critical Analysis www.americanbankingnews.com - May 13 at 11:19 AM
	ValuEngine Upgrades Senomyx (SNMX) to "Hold" www.americanbankingnews.com - May 2 at 6:06 PM
	Senomyx (SNMX) Announces Earnings Results www.americanbankingnews.com - April 27 at 3:20 PM
	Senomyx: 1Q Earnings Snapshot finance.yahoo.com - April 27 at 8:31 AM
	Senomyx misses by $0.01, misses on revenue seekingalpha.com - April 26 at 5:16 PM
	Senomyx Reports First Quarter 2018 Financial Results finance.yahoo.com - April 26 at 5:16 PM
	Analyzing Pieris Pharmaceuticals (PIRS) and Senomyx (SNMX) www.americanbankingnews.com - April 24 at 9:31 PM
	Senomyx Sets First Quarter 2018 Earnings Release Date for Thursday, April 26, 2018 at 4:05 p.m. ET finance.yahoo.com - April 20 at 8:26 AM
	Senomyx (SNMX) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - April 18 at 4:38 AM
	Senomyx: Past, Present And Future seekingalpha.com - April 5 at 5:16 PM
	BRIEF-Senomyx Board Approved Increase From Seven To Eight Directors www.reuters.com - March 23 at 8:21 AM
	Senomyx Appoints Tom Erdmann to Board of Directors finance.yahoo.com - March 22 at 8:29 AM
	Senomyx (SNMX) to Explore Strategic Alternatives www.streetinsider.com - March 21 at 8:58 AM
	Analyzing J M Smucker (SJM) and Senomyx (SNMX) www.americanbankingnews.com - March 18 at 3:28 AM
	Senomyx (SNMX) Issues Earnings Results www.americanbankingnews.com - March 9 at 10:35 AM
	Senomyx Reports Fourth Quarter and Fiscal Year 2017 Financial Results finance.yahoo.com - March 8 at 6:39 PM
	Senomyx posts 4Q profit finance.yahoo.com - March 8 at 6:39 PM
	Senomyx (SNMX) Scheduled to Post Earnings on Thursday www.americanbankingnews.com - March 1 at 8:14 PM
	Senomyx Sets Fourth Quarter and Fiscal Year 2017 Earnings Call for Thursday, March 8, 2018 at 5:00 p.m. ET finance.yahoo.com - February 27 at 8:21 AM
	Senomyx (SNMX) Upgraded by ValuEngine to Sell www.americanbankingnews.com - February 4 at 1:16 PM
	Senomyx (SNMX) Raised to Hold at Zacks Investment Research www.americanbankingnews.com - January 5 at 8:10 PM
	Senomyx to Present at 20th Annual Needham Growth Conference on January 18, 2018 finance.yahoo.com - January 5 at 8:37 AM
	Senomyx Inc www.bloomberg.com - December 31 at 8:49 AM
	Zacks Investment Research Downgrades Senomyx (SNMX) to Sell www.americanbankingnews.com - December 28 at 9:02 AM
	Short Interest in Senomyx Inc. (SNMX) Decreases By 35.8% www.americanbankingnews.com - December 16 at 3:12 AM
	Senomyx (SNMX) Downgraded by ValuEngine www.americanbankingnews.com - December 2 at 4:46 PM
	SENOMYX, INC. REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT finance.yahoo.com - November 30 at 8:42 AM
	Senomyx (SNMX) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - November 29 at 8:04 AM
	ETFs with exposure to Senomyx, Inc. : November 21, 2017 finance.yahoo.com - November 22 at 8:19 AM
	Senomyx, Inc. (SNMX) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - November 22 at 6:48 AM
	Senomyx, Inc. (SNMX) Upgraded to Sell at ValuEngine www.americanbankingnews.com - November 20 at 10:20 PM
	Senomyx: A Christmas Present For Investors seekingalpha.com - November 17 at 1:55 PM
	Zacks: Brokerages Expect Senomyx, Inc. (SNMX) to Post -$0.05 Earnings Per Share www.americanbankingnews.com - November 16 at 3:32 PM
	Senomyx Expands Cool Program Collaboration with Firmenich finance.yahoo.com - November 14 at 8:03 AM
	ETFs with exposure to Senomyx, Inc. : November 7, 2017 finance.yahoo.com - November 9 at 1:45 PM
	Senomyx, Inc. :SNMX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 6, 2017 finance.yahoo.com - November 7 at 10:34 AM
	Senomyx, Inc. to Host Earnings Call finance.yahoo.com - November 4 at 4:06 PM
	Senomyx Reports Third Quarter 2017 Financial Results finance.yahoo.com - November 4 at 4:06 PM
	Senomyx reports 3Q loss finance.yahoo.com - November 4 at 4:06 PM
	Edited Transcript of SNMX earnings conference call or presentation 2-Nov-17 9:00pm GMT finance.yahoo.com - November 4 at 4:06 PM
	Senomyx, Inc. (SNMX) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS www.americanbankingnews.com - November 3 at 4:02 PM
	Senomyx Sets Third Quarter 2017 Earnings Call for Thursday, November 2, 2017 at 5:00 p.m. ET finance.yahoo.com - October 28 at 6:24 AM
	Senomyx, Inc. (SNMX) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - October 18 at 3:44 AM
	Head to Head Contrast: Senomyx (SNMX) and Its Peers www.americanbankingnews.com - October 15 at 4:08 PM
	Senomyx (SNMX) vs. Concert Pharmaceuticals (CNCE) Financial Contrast www.americanbankingnews.com - October 15 at 10:20 AM
	Should You Buy Senomyx Inc (SNMX) For This Reason? finance.yahoo.com - October 6 at 11:34 AM
	Senomyx, Inc. (SNMX) Expected to Post Earnings of -$0.06 Per Share www.americanbankingnews.com - September 19 at 12:32 PM
	Senomyx Engages Liolios to Lead Expanded Investor Relations Program finance.yahoo.com - August 23 at 11:48 AM
	Senomyx to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017 finance.yahoo.com - August 23 at 11:48 AM

Senomyx (NASDAQ:SNMX) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Senomyx (NASDAQ:SNMX) Income Statement, Balance Sheet and Cash Flow Statement

Senomyx (NASDAQ SNMX) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff